I understand the reasons to change the name away from "Antisense", but if asked, I would have suggested a slight name change, such as to "ANP Therapeutics" which can retain some of the past recognition & brand value amongst the pharma & investment communities. The acronym could stand for "A New Perspective" or something corny like that ...
Anyway, just my opinion...
GLTAH
I understand the reasons to change the name away from...
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.0¢ | $54.97K | 528.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 396468 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 99708 | 1 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |